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Abstract
In search for new biologically active molecules, diversity-oriented synthetic (DOS) strategies 
break through the limitation of traditional library synthesis by sampling new chemical space. 
Many natural products can be regarded as intriguing starting points for DOS, wherein 
stereochemically rich core structures may be reorganized into chemotypes which are distinctly 
different from the parent structure. Ideally such transformations should be general and involve few 
steps in order to be suited for library applications. With this objective in mind, the highly 
oxygenated natural product fumagillol has been successfully remodeled in several ways utilizing a 
reaction discovery-based approach. In reactions with amines, excellent regiocontrol in a bis-
epoxide opening/cyclization sequence can be obtained by size-dependent interaction of an 
appropriate catalyst with the parent molecule, forming either perhydroisoindole or 
perhydroisoquinoline products. Perhydroisoindoles can be further remodeled by cascade processes 
to afford either morpholinone or bridged 4,1-benzoxazepine-containing structures.
In order to identify pharmacological tools for biological processes, compound discovery 
must expand beyond the sp2-dominated synthetic libraries common in biological screening.1 
Diversity-oriented libraries have been demonstrated to occupy areas of chemical space not 
normally accessed by more traditional planar, heterocyclic libraries.2–4 One approach to 
access increasingly diverse libraries would employ natural products as starting scaffolds. A 
number of studies have exploited natural products as starting materials, including use of α-
santonin5–7 and (−)-shikimic acid8,9 to identify biologically active molecules including 5-
lipoxygenase inhibitors and aurora A kinase ligands. Other methods have focused on 
altering the core framework of natural products to create small collections of structurally 
unique compounds. A method involving catalytic, site-selective derivatization of complex 
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natural products (e.g. erythyromycin) has been demonstrated by the Miller group at 
Yale.10,11 In another study, the macrocyclic diterpenoid lathyrane was converted into a 
small collection of polycyclic structures using transannular reactions.12 The Miller group 
from Notre Dame has incorporated oxazine heterocycles into natural products bearing 1,3-
butadiene subunits employing iminonitroso Diels-Alder cycloadditions.13,14
Further evolution of these ideas would involve the creation of a diverse library of 
remodelled structures derived from a natural product, each one significantly different from 
the parent compound. Transformations utilized should allow for the incorporation of new 
functionality and ideally be carried out in a single-step or tandem processes. We therefore 
initiated a reaction discovery-based approach15–18 that meets these criteria employing a 
readily available natural product as a starting point for chemically diverse library synthesis 
(Figure 1a). The highly oxygenated natural product fumagillol (2) was chosen as the 
reactivity and proximity of the two epoxides present site(s) for potential chemistry, while the 
hydroxyl and alkene groups offer additional functionality for further diversification. Crude 
fumagillin (1), a natural product which is readily available from the fermentation broth of 
Aspergillus fumigates and can be hydrolyzed to fumagillol (2) (see Supplementary 
Information),19,20, has generated significant interest as both a synthetic target21 and for its 
anti-angiogenic properties.22–24 We envisioned a series of tandem processes which could 
remodel fumagillol into novel chemotypes as dictated by either by catalyst or reaction 
partner choice. Herein, we report our initial studies aimed at remodeling fumagillol through 
Lewis acid-promoted addition of amines.
Results and Discussion
A reaction screen15,16 was first undertaken to explore sequential aminolyses of the 1,4-bis-
epoxide. We anticipated that the sequence would be initiated at the spirocyclic epoxide, 
thereby mimicking the reactivity of fumagillin with aminopeptidase MetAP-2, the putative 
mode of its antiangiogenic activity.23 An initial reaction screen (see Supporting Figures 1–5) 
with twelve Lewis acids and four amines resulted in the conversion of the bis-epoxide motif 
into perhydroisoindole (3)25–27 and/or perhydroisoquinoline (4),28–30 compounds which 
were identifiable through several characteristic signals in 1H NMR spectra. Best results were 
obtained using p-anisidine and a metal triflate catalysis. Preliminary optimization of this 
transformation demonstrated that 2,6-di-tert-butyl-4-methylpyridine (DTBMP) as proton 
scavenger significantly improved yields, presumably by buffering adventitious triflic 
acid.31,32 Several metal triflates were subsequently investigated in a second screen and a 
linear correlation was found between the atomic radius of the metal catalyst and the 
distribution of isomeric products (Figure 1b). As metal size increased, perhydroisoindole 
product 3 was increasingly favored. Lanthanum triflate proved to be optimal for production 
of 3 with >95:5 regioselectivity (entry 2). Conversely, the smaller, bivalent-metal Zn(OTf)2 
favored formation of perhydroisoquinoline 4 (entry 8, 13:87), thereby allowing access to 
either isomer simply by changing the catalyst.33–35 In the absence of a catalyst, no reaction 
occurred and fumagillol was fully recovered.
Further optimization using La(OTf)3 and Zn(OTf)2 catalysts was next pursued. The 
transformations were robust and did not require inert atmosphere, nor special precautions for 
Balthaser et al. Page 2
Nat Chem. Author manuscript; available in PMC 2012 June 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
anhydrous solvent. Other nonpolar solvents provided similar regioselectivity, though toluene 
proved to be optimal, in which case catalyst loading could be reduced to 10 mol% while 
maintaining reasonable reaction times. Production of 3 was ultimately optimized using 
La(OTf)3 to 91% isolated yield (91:3 regioselectivity), while 4 could be obtained with 
Zn(OTf)2 in 76% yield (9:76 regioselectivity).
Bis-epoxide opening, and in particular, catalyst-controlled regioselectivity, proved to be 
quite general (Table 1). A variety of electron-rich and electron-deficient anilines produced 
either heterocyclic motif (entries 1 – 5), with La(OTf)3 catalysis forming predominantly 
perhydroisoindoles 5 and Zn(OTf)2 yielding perhydroisoquinolines 6. In the case of the 
La(III)-promoted reactions, there was a direct correlation of the nucleophilicity of the aniline 
with the reaction rate, with electron-rich amines reacting faster. The rate of formation for 
perhydroisoquinoline 6 under Zn(II)-catalysis was largely unaffected by the electronics of 
the aniline, until a sufficiently electron deficient analogue (entry 5) was used. Thus, with p-
trifluoromethylaniline, the reaction was significantly slower than with the more electron-rich 
anilines, which all proceeded at approximately the same rate. Heteroaryl amines including 2-
aminopyridine and 2-aminothiazole failed to react using either La(OTf)3 or Zn(OTf)2, in 
which case fumagillol was fully recovered.
More basic amines were also well tolerated in the reaction (entries 7 – 9), with La(III) again 
proving to be optimal for perhydroisoindole formation. It was necessary, however, to 
increase the catalyst loading to 50 mol% in order to obtain reasonable reaction times, 
presumably due to the greater basicity of these amines leading to tighter interaction with the 
catalyst. An even greater reduction in reaction rate was observed with Zn(II) catalysis, 
rendering the reaction unacceptably slow (60 h, approx. 5–10% conversion). Use of 
Mg(OTf)2 (50 mol%) as the catalyst, however, also led predominantly to the desired 
perhydroisoquinoline products (6f – 6g) in acceptable reaction times (entries 7 – 9, 16 – 36 
hrs). Addition of aromatic and aliphatic secondary amines were also carried out providing 
highly substituted tetrahydrofuran products 7 and 8, both isolated as triflate salts (Table 1, 
entries 10 and 11).
Insights into the interaction of metal catalysts with fumagillol were achieved through a 
series of 13C NMR experiments (Figure 2, Supplementary Figure 6). In the 13C NMR 
spectra of fumagillol obtained with 2 mol% of paramagnetic catalysts Yb(OTf)3 (r = 175 
pm) or Fe(OTf)2 (r = 140 pm),35,36 broadening of the C5 and C6 resonances was observed, 
indicating that different sized metals are preferentially bound to the pocket formed by the 
hydroxyl and methoxy groups of fumagillol (7). The same interaction was not observed in 
the C6-silylated analogue 10, with only modest broadening of the C2, C1′, and C2′ signals 
observed.
To probe the importance of the interactions observed by 13C NMR, selectivity of silyl ether 
11 under the optimized reaction conditions was evaluated. When 11 was reacted with 
several anilines, the regioselectivity obtained with La(III) catalysis inverted, leading 
predominantly to perhydroisoquinoline products as originally found in the Zn(II)-catalyzed 
reactions (Figure 2b). By comparison, reaction of 11 using Zn(II) became more selective to 
afford perhydroisoquinolines providing greater than 20:1 selectivity. These results suggest a 
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mechanism wherein coordination of the metal to the C6 hydroxyl group of fumagillol with 
different sized metals greatly affects the regiochemical outcome, either through multidentate 
ligand effects and/or conformational control.
The observed regioselectivity can be rationalized from a model of metal-coordinated amino 
alcohol intermediate 14, obtained from opening of the more labile spirocyclic epoxide 
(Figure 2c).37,38 The larger La(III) catalyst may more easily accommodate the C6 hydroxyl 
group simultaneously with C1′ epoxide activation (cf. 15), thereby leading to tridentate 
coordination to the substrate wherein the amine is positioned closer and at a more optimal 
trajectory for addition to C1′. In contrast, smaller metals such as Zn(II) which cannot as 
easily accommodate the C6 hydroxyl while activating the second epoxide may adopt a 
looser bidentate coordination which places C2′ closer the amine (cf. 16). In the case of 
Zn(II) catalysis, activation of the second epoxide through adoption of 16 may be rate 
determining, as perhydroisoquinoline formation appeared to be largely independent of 
aniline nucleophilicity. Further studies to understand the precise mechanism leading to 
selectivity are currently underway.
The methodology was further extended by the use of L- and D-phenylalanine methyl esters 
which underwent lactonization after initial epoxide opening (Figure 3a). With Mg(OTf)2 as 
catalyst, perhydroisoquinoline products 17 and 19, respectively, were produced in 
approximately 3:1 regioselectivity relative to the perhydroisoindole- derived products (18, 
and 20/21, respectively) for each amino acid. Further lactonization of the 
perhydroisoquinoline analogues was not observed. In comparison, the perhydroisoindole 
formed with D-phenylalanine (catalyzed by La(OTf)3) lactonized in situ to afford the 
polycyclic morpholinone derivative 18. Reaction with L-phenylalanine, however, formed 
isoindole 20 and morpholinone 21 in a 4:1 ratio. The observed resistance to lactonization of 
21 can be rationalized from steric congestion caused by the additional pseudoaxial prenyl 
substituent at C2′ which was calculated to be 3.1 kcal/mol higher in energy relative to 
diastereomer 18 (Supplementary Figure 7). Lactonization of 20 could eventually be 
accomplished under basic conditions to yield morpholinone 21 (85%).
Reaction of 1 with 2-ethynylaniline under Mg(OTf)2 catalysis produced 
perhydroisoquinoline 22, while La(III) afforded the expected perhydroisoindole product 23 
(Figure 4a). Upon extended reaction times (48 h) with La(OTf)3 or at elevated temperature 
(90 °C), the novel 4,1-benzoxazepine39–41 24 bearing a [4.2.1] ring system was formed from 
23 in a highly efficient cascade process.42–45 Benzoxazepine 24 is presumably formed by 
initial hydroalkoxylation of the alkynyl alcohol of 23 to enol ether 2546,47 followed by 
protonation to oxonium 26 (Figure 4b). Subsequent Prins cyclization48 forms 4,1-
benzoxazepine 24, thereby providing a dramatic example of natural product remodeling via 
an unanticipated cascade sequence.
In summary, the natural product fumagillol has been selectively remodeled into a series of 
perhydroisoindoles and perhydroisoquinolines through sequential ring-opening with amines. 
Regiocontrol was achieved through choice of metal triflate catalysts, with smaller Zn(II) and 
Mg(II) catalysts leading to perhydroisoquinolines, while the larger La(III) catalyst favored 
production of perhydroisoindoles. Addition of secondary amines provided highly substituted 
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tetrahydrofurans. Perhydrosoindole products underwent further reactions, including 
lactonizations employing amino acid esters as epoxide-opening nucleophiles and bridged 
4,1-benzoxazepines from an unexpected cascade sequence with 2-ethynylaniline. 
Remodeled structures produced in this study are currently being examined in a range of 
biological screens, including those as part of the Molecular Libraries Probe Production 
Centers Network (MLPCN, http://mli.nih.gov/mli/) and the NIMH Psychoactive Drug 
Screening Program (PDSP, http://pdsp.med.unc.edu/indexR.html). These studies should 
pave the way for work to remodel other natural product scaffolds to access novel 
chemotypes and pharmacological tools.
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Figure 1. Natural Product Remodeling using Fumagillol
a, Fumagillol can be transformed into multiple chemotypes through a panel of related 
reaction conditions. Fumagillol was obtained by hydrolysis of crude fumagillin isolated 
from the fermentation broth of Aspergillus fumigatus. b, a) M(OTf)n (10 mol%), p-anisidine 
(1.1 equiv.), DTBMP (60 mol%), toluene, 60 °C, 20 h; DTBMP = 2,6-di-tert-butyl-4-
methylpyridine.
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Figure 2. Mechanistic Studies
a, Metals of different sizes preferentially coordinate to the C-6 hydroxyl and C-5 methyl 
ether of fumagillol by 13C NMR. b, Epoxide opening of TMS-protected fumagillol shows an 
inversion of regioselectivity; a) amine (1.1 equiv.), M(OTf)n (10 mol%), DTBMP (60 mol
%), toluene, 60 °C; b) TMSCl, imdazole, DMAP, CH2Cl2, 83%; c) isolated yields; d) ratio 
by 1H NMR. c, A working model demonstrating the role of the C-6 hydroxyl toward 
regioselectivity; DMAP = 4-dimethylaminopyridine, DTBMP = 2,6-di-tert-butyl-4-
methylpyridine, TMS = trimethylsilyl.
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Figure 3. Use of amino acid esters as reaction partners
a, Selective formation of perhydroisoindoles, perhydroisoquinolines, or morpholinones with 
phenylalanine; a) amine (2.0 equiv.), M(OTf)n (50 mol%), DTBMP (1.5 equiv.), toluene, 60 
°C; b) NaOH (2.0 M), THF, rt, 6 h; DTBMP = 2,6-di-tert-butyl-4-methylpyridine, Phe = 
phenylalanine. b, Molecular models of the phenylalanine-derived morpholinones 18 and 21.
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Figure 4. Reaction with 2-ethynylaniline
a, Selective formation of a perhydroisoindole, perhydroisoquinoline, or 4,1-benzoxazepine; 
DTBMP = 2,6-di-tert-butyl-4-methylpyridine. b, A novel cascade process to form a 4,1-
benzoxazepine.
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